Studies have shown that YTHDF1 and YTHDF2 mRNA expression levels are positively correlated with malignancy of gliomas, with significant increases in higher grade gliomas, suggesting a role for these m6A readers in glioma progression (65, 69) (Figure 3). The gene discussed is YTHDF1; the disease is central nervous system cancer.